Caffeine is indicated for:
Primary apnoea of premature newborns
Irrespective of gender only Newborns (0 - 40 days old)
Cafferine is indicated for the treatment of primary apnoea of premature newborns.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 5-20 mg/kg body weight
Active ingredient Caffeine is contraindicated in the following cases: